Outset Medical
(NASDAQ) OM
Outset Medical Financials at a Glance
Market Cap
$73.43M
Revenue (TTM)
$119.48M
Net Income (TTM)
$81.65M
EPS (TTM)
$-6.81
P/E Ratio
-0.59
Dividend
$0.00
Beta (Volatility)
1.28 (Average)
Dividend
$0.00
Beta (Volatility)
1.28 (Average)
Price
$4.00
Volume
95,741
Open
$3.72
Price
$4.00
Volume
95,741
Open
$3.72
Previous Close
$4.01
Daily Range
$3.65 - $4.04
52-Week Range
$3.00 - $21.98
Dividend
$0.00
Beta (Volatility)
1.28 (Average)
Price
$4.00
Volume
95,741
Open
$3.72
Previous Close
$4.01
Daily Range
$3.65 - $4.04
52-Week Range
$3.00 - $21.98
OM News
OM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Outset Medical
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
310
CEO
Leslie L. Trigg, MBA
Website
www.outsetmedical.comHeadquarters
San Jose, CA 95134, US
OM Financials
Key Financial Metrics (TTM)
Gross Margin
39%
Operating Margin
-56%
Net Income Margin
-68%
Return on Equity
-106%
Return on Capital
-29%
Return on Assets
-31%
Earnings Yield
-1.69%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$73.43M
Shares Outstanding
18.31M
Volume
95.74K
Short Interest
0.00%
Avg. Volume
737.30K
Financials (TTM)
Gross Profit
$46.75M
Operating Income
$66.71M
EBITDA
$62.37M
Operating Cash Flow
$46.33M
Capital Expenditure
$798.00K
Free Cash Flow
$47.13M
Cash & ST Invst.
$168.95M
Total Debt
$104.52M
Outset Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$28.87M
-2.0%
Gross Profit
$12.23M
+13.8%
Gross Margin
42.36%
N/A
Market Cap
$73.43M
N/A
Market Cap/Employee
$207.43K
N/A
Employees
354
N/A
Net Income
$19.49M
+24.0%
EBITDA
$16.46M
+10.6%
Quarterly Fundamentals
Net Cash
$64.43M
+249.2%
Accounts Receivable
$28.33M
-20.5%
Inventory
$47.61M
-19.8%
Long Term Debt
$102.78M
-48.6%
Short Term Debt
$1.74M
-51.7%
Return on Assets
-30.87%
N/A
Return on Invested Capital
-29.28%
N/A
Free Cash Flow
$9.74M
+41.1%
Operating Cash Flow
$9.52M
+42.3%